Immunophenotyping assessment in a COVID-19 cohort (IMPACC): A prospective longitudinal study

Monica Kraft(University of Arizona), Joann Diray‐Arce(Boston Children's Hospital), Hanno Steen(Broad Institute), Charles Langelier(University of California, San Francisco), David A. Hafler(Yale University), Leying Guan(Yale University), Alyssa Ward(University of California, San Francisco), Steven M. Sigelman, Kerry McEnaney, Lauren I. R. Ehrlich(Livestrong Foundation), David J. Erle(University of California, San Francisco), Adeeb Rahman(Immunai (United States)), Michael R. Wilson(University of California, San Francisco), Bjoern Peters(La Jolla Institute for Immunology), Nelson Agudelo Higuita, Mark M. Davis(Stanford Medicine), Charles B. Cairns(Drexel University), Nadine Rouphael(Emory University), Christian Bime, Steven E. Bosinger(Emory University), Farrah Kheradmand(Baylor College of Medicine), Colin R. Zamecnik(University of California, San Francisco), Catherine L. Hough(Oregon Health & Science University), Elaine F. Reed(University of California, Los Angeles), Mark A. Atkinson(University of Florida), Harm van Bakel(Icahn School of Medicine at Mount Sinai), Carolyn S. Calfee(University of California, San Francisco), Ofer Levy(Broad Institute), Prescott G. Woodruff(University of California, San Francisco), Holden T. Maecker(Stanford University), Florian Krammer(Semmelweis University), David B. Corry(Baylor College of Medicine), Ana Fernández-Sesma(The Graduate Center, CUNY), Scott C. Brakenridge(University of Florida), Alison D. Augustine, Lindsey R. Baden(Brigham and Women's Hospital), Elias K. Haddad(Drexel University), Walter L. Eckalbar(University of California, San Francisco), Jayant V. Rajan
Science Immunology
August 10, 2021
Cited by 74


Related Papers